Skip to content

the establishment of upper urinary tract endoscopic diagnosis and treatment system for patients with recurrent painless hematuria

the establishment of upper urinary tract endoscopic diagnosis and treatment system for patients with recurrent painless hematuria

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069961
Enrollment
Unknown
Registered
2023-03-30
Start date
2023-04-01
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

recurrent painless hematuria

Interventions

rigid and flexiable ureteroscopy group:flexiable ureteroscopy combined with rigid ureteroscopy
simple flexialbe ureteroscopy group:flexiable ureteroscopy
stage endoscopy group (intervals 1-2 weeks):stage endoscopic examination of bilateral upper urinary tract
simultaneous endoscopy group :simultaneous endoscopic examination of bilateral upper urinary tract
After endoscopy, routine DJ tube group:indent DJ tube
After endoscopy, without DJ tube group :do not indent DJ tube
upper urinary tract tumor endoscopic treatment group:endoscopic resection of the upper urinary tumor
upper urinary tract tumor conventional treatment group :routine radical operation

Sponsors

Emergency General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: (1) Patients with recurrent painless hematuria (more than 3 times, each interval more than 1 month); (2) Negative CTU and urinary cytology; (3) Age 18 years or above; (4) No mental abnormalities, verbal communication barrier-free, with autonomy; (5) Obtain the consent of the patient and family members,voluntary participation, and sign informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients with bleeding sites located in bladder and urethra were identified; (2) Hematuria due to suspected systemic causes or anticoagulant drugs; (3) With serious underlying diseases; (4) Inability to undergo general anesthesia; (5) Inability to tolerate or refuse flexiable/rigid ureteroscopy; (6) Unwillingness or inability to follow up; (7) Have other reasons reseachers cited for not participating in the study.

Design outcomes

Primary

MeasureTime frame
hospital stays;operation duration;medical expenses;common complication;dynamic changes of renal function after endoscopic operation;serious complication;endoscopic diagnostic sensitivity;endoscopic diagnostic specificity;success rate of endoscopic treatment;tumor recurrence rate;hematuria recurrence rate;

Secondary

MeasureTime frame
tumor progression-free survival;overall survival;

Countries

China

Contacts

Public ContactJianliang Cai

Emergency General Hospital

jlcai@bjmu.edu.cn+86 10 87935638

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026